Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 948951, 10 pages
http://dx.doi.org/10.1155/2014/948951
Research Article

Ovarian Aging-Like Phenotype in the Hyperandrogenism-Induced Murine Model of Polycystic Ovary

1Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 1417614411, Iran
2Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran 1417614411, Iran
3Centre de Recherche en Biologie de la Reproduction, Université Laval, Québec City, QC, Canada G1V 0A6
4Faculty of Medicine, Tehran University of Medical Sciences, Tehran 1417614411, Iran
5Pharmacology and Applied Medicine Department of Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Alborz 141554364, Iran
6International Campus, Tehran University of Medical Sciences (ICTUMS), Tehran 1417653861, Iran

Received 28 November 2013; Accepted 2 January 2014; Published 19 February 2014

Academic Editor: Sara Mostafalou

Copyright © 2014 Mohammad Amin Rezvanfar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. C. Gore, D. M. Walker, A. M. Zama, A. E. Armenti, and M. Uzumcu, “Early life exposure to endocrine-disrupting chemicals causes lifelong molecular reprogramming of the hypothalamus and premature reproductive aging,” Molecular Endocrinology, vol. 25, no. 12, pp. 2157–2168, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. Ottinger, “Mechanisms of reproductive aging: conserved mechanisms and environmental factors,” Annals of the New York Academy of Sciences, vol. 1204, pp. 73–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. Q. Li, X. Geng, W. Zheng, J. Tang, B. Xu, and Q. Shi, “Current understanding of ovarian aging,” Science China Life Sciences, vol. 55, no. 8, pp. 659–669, 2012. View at Google Scholar
  4. A. B. Salmon, A. Richardson, and V. I. Pérez, “Update on the oxidative stress theory of aging: does oxidative stress play a role in aging or healthy aging?” Free Radical Biology and Medicine, vol. 48, no. 5, pp. 642–655, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Agarwal, A. Aponte-Mellado, B. J. Premkumar, A. Shaman, and S. Gupta, “The effects of oxidative stress on female reproduction: a review,” Reproductive Biology and Endocrinology, vol. 10, no. 49, pp. 1477–7827, 2012. View at Google Scholar
  6. C. Tatone, F. Amicarelli, M. C. Carbone et al., “Cellular and molecular aspects of ovarian follicle ageing,” Human Reproduction Update, vol. 14, no. 2, pp. 131–142, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. C. K. Welt and E. Carmina, “Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause,” The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 12, pp. 4629–4638, 2013. View at Publisher · View at Google Scholar
  8. V. De Leo, A. La Marca, and F. Petraglia, “Insulin-lowering agents in the management of polycystic ovary syndrome,” Endocrine Reviews, vol. 24, no. 5, pp. 633–667, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. L. J. Moran, M. L. Misso, R. A. Wild, and R. J. Norman, “Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis,” Human Reproduction Update, vol. 16, no. 4, pp. 347–363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. W. A. March, V. M. Moore, K. J. Willson, D. I. W. Phillips, R. J. Norman, and M. J. Davies, “The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria,” Human Reproduction, vol. 25, no. 2, pp. 544–551, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Murri, M. Luque-Ramirez, M. Insenser, M. Ojeda-Ojeda, and H. F. Escobar-Morreale, “Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis,” Human Reproduction Update, vol. 19, no. 3, pp. 268–288, 2013. View at Google Scholar
  12. H. F. Escobar-Morreale, M. Luque-Ramírez, and F. González, “Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis,” Fertility and Sterility, vol. 95, no. 3, pp. 1048–e2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. O. Goodarzi, D. A. Dumesic, G. Chazenbalk, and R. Azziz, “Polycystic ovary syndrome: etiology, pathogenesis and diagnosis,” Nature Reviews Endocrinology, vol. 7, no. 4, pp. 219–231, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. B. Motta, “Dehydroepiandrosterone to induce murine models for the study of polycystic ovary syndrome,” Journal of Steroid Biochemistry and Molecular Biology, vol. 119, no. 3–5, pp. 105–111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Shirwalkar, D. N. Modi, and A. Maitra, “Exposure of adult rats to estradiol valerate induces ovarian cyst with early senescence of follicles,” Molecular and Cellular Endocrinology, vol. 272, no. 1-2, pp. 22–37, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. H. Park and T. S. Choi, “Polycystic ovary syndrome (PCOS)-like phenotypes in the d-galactose-induced aging mouse model,” Biochemical and Biophysical Research Communications, vol. 427, no. 4, pp. 701–704, 2012. View at Google Scholar
  17. M. A. Rezvanfar, M. A. Rezvanfar, A. Ahmadi, H. A. Shojaei Saadi, M. Baeeri, and M. Abdollahi, “Mechanistic links between oxidative/nitrosative stress and tumor necrosis factor alpha in letrozole-induced murine polycystic ovary Biochemical and pathological evidences for beneficial effect of pioglitazone,” Human & Experimental Toxicology, vol. 31, no. 9, pp. 887–897, 2011. View at Google Scholar
  18. M. A. Rezvanfar, M. A. Rezvanfar, A. Ahmadi, H. A. Shojaei-Saadi, M. Baeeri, and M. Abdollahi, “Molecular mechanisms of a novel selenium-based complementary medicine which confers protection against hyperandrogenism-induced polycystic ovary,” Theriogenology, vol. 78, no. 3, pp. 620–631, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. A. Rezvanfar, M. A. Rezvanfar, A. R. Shahverdi et al., “Protection of cisplatin-induced spermatotoxicity, DNA damage and chromatin abnormality by selenium nano-particles,” Toxicology and Applied Pharmacology, vol. 266, no. 3, pp. 356–365, 2013. View at Google Scholar
  20. M. Pakzad, S. Fouladdel, A. Nili-Ahmadabadi et al., “Sublethal exposures of diazinon alters glucose homostasis in Wistar rats: biochemical and molecular evidences of oxidative stress in adipose tissues,” Pesticide Biochemistry and Physiology, vol. 105, pp. 57–5[, 2012. View at Google Scholar
  21. P. Hasani, N. Yasa, S. Vosough-Ghanbari, A. Mohammadirad, G. Dehghan, and M. Abdollahi, “In vivo antioxidant potential of Teucrium polium, as compared to α-tocopherol,” Acta Pharmaceutica, vol. 57, no. 1, pp. 123–129, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Hosseini-Tabatabaei, H. Esmaily, R. Rahimian et al., “Benefit of nicorandil using an immunologic murine model of experimental colitis,” Central European Journal of Biology, vol. 4, no. 1, pp. 74–85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Seino, H. Saito, T. Kaneko, T. Takahashi, S. Kawachiya, and H. Kurachi, “Eight-hydroxy-2′-deoxyguanosine in granulosa cells is correlated with the quality of oocytes and embryos in an in vitro fertilization-embryo transfer program,” Fertility and Sterility, vol. 77, no. 6, pp. 1184–1190, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. S. A. Lund, J. Murdoch, E. A. Van Kirk, and W. J. Murdoch, “Mitogenic and antioxidant mechanisms of estradiol action in preovulatory ovine follicles: relevance to luteal function,” Biology of Reproduction, vol. 61, no. 2, pp. 388–392, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Poretsky, J. Clemons, and K. Bogovich, “Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats,” Metabolism, vol. 41, no. 8, pp. 903–910, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. D. A. Dumesic and J. S. Richards, “Ontogeny of the ovary in polycystic ovary syndrome,” Fertility Sterility, vol. 100, no. 1, pp. 23–38, 2013. View at Google Scholar
  27. P. E. Hughesdon, “Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called 'hyperthecosis',” Obstetrical and Gynecological Survey, vol. 37, no. 2, pp. 59–77, 1982. View at Google Scholar · View at Scopus
  28. H. Billig, I. Furuta, and A. J. W. Hsueh, “Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis,” Endocrinology, vol. 133, no. 5, pp. 2204–2212, 1993. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Belgorosky, V. Analía Sander, M. P. Di Yorio, A. G. Faletti, and A. B. Motta, “Hyperandrogenism alters intraovarian parameters during early folliculogenesis in mice,” Reproductive BioMedicine Online, vol. 20, no. 6, pp. 797–807, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Jonard and D. Dewailly, “The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest,” Human Reproduction Update, vol. 10, no. 2, pp. 107–117, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Y. Lee, C. K. Baw, S. Gupta, N. Aziz, and A. Agarwal, “Role of oxidative stress in polycystic ovary syndrome,” Current Women's Health Reviews, vol. 6, pp. 96–107, 2010. View at Google Scholar
  32. R. A. Kireev, A. C. F. Tresguerres, C. Garcia et al., “Hormonal regulation of pro-inflammatory and lipid peroxidation processes in liver of old ovariectomizedfemale rats,” Biogerontology, vol. 11, no. 2, pp. 229–243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. G. F. Oxenkrug, “Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan—kynurenine metabolism,” Annals of the New York Academy of Sciences, vol. 1199, pp. 1–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. D. D. Haines, B. Juhasz, and A. Tosaki, “Management of multicellular senescence and oxidative stress,” Journal of Cellular and Molecular Medicine, pp. 1–22, 2013. View at Google Scholar
  35. Y. Zhang, B.-S. Herbert, G. Rajashekhar et al., “Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-α via the p38 mitogen-activated protein kinase pathway,” FASEB Journal, vol. 23, no. 5, pp. 1358–1365, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Cui, Y. Kong, and H. Zhang, “Oxidative stress, mitochondrial dysfunction, and aging,” Journal of Signal Transduction, vol. 2012, Article ID 646354, 13 pages, 2012. View at Publisher · View at Google Scholar
  37. K. Rosewell, L. Al-Alem, F. Li, B. Kelty, and T. E. Curry Jr., “Identification of hepsin and protein disulfide isomerase A3 as targets of gelatinolytic action in rat ovarian granulosa cells during the periovulatory period,” Biology of Reproduction, vol. 85, no. 4, pp. 858–866, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. K. C. Lewandowski, J. Komorowski, C. J. O'Callaghan et al., “Increased circulating levels of matrix metalloproteinase-2 and -9 in women with the polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 3, pp. 1173–1177, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. V. A. Gomes, C. S. Vieira, A. L. Jacob-Ferreira et al., “Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome,” Molecular and Cellular Biochemistry, vol. 353, no. 1-2, pp. 251–257, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. X. Liao, J. B. Thrasher, J. Pelling, J. Holzbeierlein, Q.-X. A. Sang, and B. Li, “Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer,” Endocrinology, vol. 144, no. 5, pp. 1656–1663, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Goldman and E. Shalev, “MMPS and TIMPS in ovarian physiology and pathophysiology,” Frontiers in Bioscience, vol. 9, pp. 2474–2483, 2004. View at Google Scholar · View at Scopus
  42. V. J. Cristofalo, C. Volker, M. K. Francis, and M. Tresini, “Age-dependent modifications of gene expression in human fibroblasts,” Critical Reviews in Eukaryotic Gene Expression, vol. 8, no. 1, pp. 43–80, 1998. View at Google Scholar · View at Scopus
  43. E. Acuña, R. Fornes, D. Fernandois et al., “Increases in norepinephrine release and ovarian cyst formation during ageing in the rat,” Reproductive Biology and Endocrinology, vol. 7, article 64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. R. K. Gupta, K. P. Miller, J. K. Babus, and J. A. Flaws, “Methoxychlor inhibits growth and induces atresia of antral follicles through an oxidative stress pathway,” Toxicological Sciences, vol. 93, no. 2, pp. 382–389, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Bukovskya, M. E. Ayala, R. Dominguez et al., “Postnatal androgenization induces premature aging of rat ovaries,” Steroids, vol. 65, no. 4, pp. 190–205, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. A. R. Genazzani, N. Pluchino, S. Luisi, and M. Luisi, “Estrogen, cognition and female ageing,” Human Reproduction Update, vol. 13, no. 2, pp. 175–187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. N. I. Parikh, S. Cnattingius, M. A. Mittleman, J. F. Ludvigsson, and E. Ingelsson, “Subfertility and risk of later life maternal cardiovascular disease,” Human Reproduction, vol. 27, no. 2, pp. 568–575, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. R. D. Semba, E. J. Nicklett, and L. Ferrucci, “Does accumulation of advanced glycation end products contribute to the aging phenotype?” The Journals of Gerontology Series A, vol. 65, no. 9, pp. 963–975, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Szafarowska and M. Jerzak, “Ovarian aging and infertility,” Ginekologia Polska, vol. 84, no. 4, pp. 298–304, 2013. View at Google Scholar
  50. E. Diamanti-Kandarakis, C. Piperi, E. Patsouris et al., “Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries,” Histochemistry and Cell Biology, vol. 127, no. 6, pp. 581–589, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Diamanti-Kandarakis, I. Katsikis, C. Piperi et al., “Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS),” Clinical Endocrinology, vol. 69, no. 4, pp. 634–641, 2008. View at Publisher · View at Google Scholar · View at Scopus